Schizophrenia Research
Volume 116, Issue 1 , Pages 90-96 , January 2010

Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients

  • Michael A. Rapp

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10128, USA
    • Department of Psychiatry, Charite Campus Mitte, 10117 Berlin, Germany
    • Corresponding Author InformationCorresponding author. Present Address: Department of Psychiatry, Charite Campus Mitte, Chariteplatz 1, D-10117 Berlin, Germany. Tel.: +49 30 2311 2959; fax: +49 30 2311 2952.
    • ,
  • Michal Schnaider-Beeri

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10128, USA
    • ,
  • Dushyant P. Purohit

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10128, USA
    • Department of Pathology, Mount Sinai School of Medicine, New York, NY 10128, USA
    • ,
  • Abraham Reichenberg

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10128, USA
    • Bronx Veterans Affairs Hospital, Bronx, NY 10468, USA
    • ,
  • Susan R. McGurk

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10128, USA
    • ,
  • Vahram Haroutunian

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10128, USA
    • Institute of Psychiatry, London SE5 8AF, UK
    • ,
  • Philip D. Harvey

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10128, USA
    • Department of Psychiatry, Emory University, Atlanta, GA 30322, USA

Received 10 May 2009 ,Revised 12 October 2009 ,Accepted 17 October 2009.

References 

  1. Akbarian S, Bunney WE, Potkin SG, Wigal SB, Hagman JO, Sandman CA, et al. Altered distribution of nicotinamide–adenine dinucleotide phosphate–diphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry. 1993;50:169–177
  2. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE, Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brain of the schizophrenic patients. Arch. Gen. Psychiatry. 1996;53:425–436
  3. Alzheimer A. Beiträge zur Pathologischen Anatomie der Hirnrinde und zur anatomischen Grundlage der Psychosen. Mschr. Psychiat. Neurol. 1897;2:82–112
  4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987;
  5. Arnold SE. Contributions of neuropathology to understanding schizophrenia in late life. Harv. Rev. Psychiatry. 2001;9(2):69–76
  6. Arnold SE, Franz BR, Trojanowski JQ. Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol. Aging. 1994;15:299–303
  7. Baldessarini RJ, Hegarty JD, Bird ED, Benes FM. Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia. Am. J. Psychiatry. 1997;154(6):861–863
  8. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry. 1991;48:996–1001
  9. Benes FM, Sorensen I, Vincent SL, Bird ED, Sathi M. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brains. Cereb. Cortex. 1992;2:503–512
  10. Berg L. Clinical Dementia Rating (CDR). Psychopharmacol. Bull. 1988;24(4):637–639
  11. Bogerts B. The neuropathology of schizophrenic diseases: historical aspects and present knowledge. Eur. Arch. Psychiatry Clin. Neurosci. 1999;249(S4):2–13
  12. Borenstein Graves A, Mortimer JA, Bowen JD, McCormick WC, McCurry SM, Schellenberg GD, et al. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. Neurology. 2001;57(8):1453–1460
  13. Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DG, Roberts GW. Schizophrenia and the brain: a prospective clinico-neuropathological study. Psychol. Med. 1990;20(2):285–304
  14. Buhl L, Bojsen-Moller M. Frequency of Alzheimer's disease in a postmortem study of psychiatric patients. Dan. Med. Bull. 1988;35:288–290
  15. Buhrich N, Crow TJ, Johnstone EC, Owens DG. Age disorientation in chronic schizophrenia is not associated with pre-morbid intellectual impairment or past physical treatment. Br. J. Psychiatry. 1988;152:466–469
  16. Davidson M, Harvey PD, Powchik P, Parrella M, White L, Knobler HY, et al. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am. J. Psychiatry. 1995;152:197–207
  17. Dwork AJ, Susser ES, Keilp J, Waniek C, Liu D, Kaufman M, et al. Senile degeneration and cognitive impairment in chronic schizophrenia. Am. J. Psychiatry. 1998;155:1536–1543
  18. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Psychiatry Res. 1975;12:189–198
  19. Friedman JI, Harvey PD, Coleman T, Moriarty PJ, Bowie C, Parrella M, et al. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am. J. Psychiatry. 2001;158(9):1441–1448
  20. Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A. The consortium to establish a registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology. 1995;45(3):461–466
  21. Haroutunian V, Perl DP, Purohit DP, Marin D, Khan K, Lantz M, et al. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch. Neurol. 1998;55(9):1185–1191
  22. Harvey PD, Silverman JM, Mohs RC, Parrella M, White L, Powchik P, et al. Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol. Psychiatry. 1999;45(1):32–40
  23. Harvey PD, Friedman JI, Bowie C, Reichenberg A, McGurk SR, Parrella M, et al. Validity and stability of performance-based estimates of premorbid educational functioning in older patients with schizophrenia. J. Clin. Exp. Neuropathol. 2006;28:178–192
  24. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 1990;31:545–548
  25. Holt DJ, Bachus SE, Hyde TM, Wittie M, Herman MM, Vangel M, et al. Reduced density of cholinergic interneurons in the ventral striatum in schizophrenia: an in situ hybridization study. Biol. Psychiatry. 2005;58(5):408–416
  26. Johnstone EC, Owens DG, Gold A, Crow TJ, MacMillan JF. Institutionalization and the defects of schizophrenia. Br. J. Psychiatry. 1981;139:195–203
  27. Karson CN, Mrak RE, Husain MM, Griffin WS. Decreased mesopontine choline acetyltransferase levels in schizophrenia. Correlations with cognitive functions. Mol. Chem. Neuropathol. 1996;29(2–3):181–191
  28. Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) manual. Schizophr. Bull. 1987;13:261–276
  29. Kim KR, Lee KS, Kim EA, Cheong HK, Oh BH, Hong CH. The effect of the ApoE genotype on the association between head circumference and cognition. Am. J. Geriatr. Psychiatry. 2008;16(10):819–825
  30. Kraepelin E. Dementia praecox and paraphrenia. Bristol: Thoemmes Press; 2002;
  31. Lynch CA, Walsh C, Blanco A, Moran M, Coen RF, Walsh JB, et al. The Clinical dementia rating sum of box score in mild dementia. Dement. Geriatr. Cogn. Disord. 2006;21:40–43
  32. Powchik P, Davidson M, Haroutunian V, Gabriel SM, Purohit DP, Perl DP, et al. Postmortem studies in schizophrenia. Schizophr. Bull. 1998;24(3):325–341
  33. Prohovnik I, Dwork AJ, Kaufman MA, Willson N. Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr. Bull. 1993;19:805–816
  34. Purohit DP, Davidson M, Perl DP, Powchik P, Haroutunian VH, Bierer LM, et al. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol. Psychiatry. 1993;33:255-260
  35. Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis KL. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch. Gen. Psychiatry. 1998;55:205–211
  36. Rapp MA, Schnaider-Beeri M, Grossman HT, Sano M, Perl DP, Purohit DP, et al. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch. Gen. Psychiatry. 2006;63(2):161–167
  37. Reichenberg A, Weiser M, Rabinowitz J, Caspi A, Schmeidler J, Mark M, et al. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am. J. Psychiatry. 2002;159(12):2027–2035
  38. Reichenberg A, Weiser M, Rapp MA, Rabinowitz J, Caspi A, Schmeidler J, et al. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch. Gen. Psychiatry. 2005;62(12):1297–1304
  39. Religa D, Laudon H, Styczynska M, Winblad B, Naslund J, Haroutunian V. Amyloid beta pathology in Alzheimer's disease and schizophrenia. Am. J. Psychiatry. 2003;60(5):867–872
  40. Sorbi S, Nacmias B, Tedde A, Latorraca S, Forleo P, Guarnieri BM, et al. No implication of apolipoprotein E polymorphism in Italian schizophrenic patients. Neurosci. Lett. 1998;244(2):118–120
  41. Spalletta G, Bernardini S, Bellincampi L, Federici G, Trequattrini A, Caltagirone C. Delusion symptoms are associated with ApoE epsilon4 allelic variant at the early stage of Alzheimer's disease with late onset. Eur. J. Neurol. 2006;13(2):176–182
  42. Taylor MA, Abrams R. Cognitive impairment in schizophrenia. Am. J. Psychiatry. 1984;141:196–201

PII: S0920-9964(09)00500-3

doi: 10.1016/j.schres.2009.10.013

Schizophrenia Research
Volume 116, Issue 1 , Pages 90-96 , January 2010

Article Tools